Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989093449> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W1989093449 endingPage "458" @default.
- W1989093449 startingPage "454" @default.
- W1989093449 abstract "Abstract Adjuvant chemotherapy decreases the risk of breast cancer recurrence in patients with breast cancer. In addition, it increases the rate of survival. Therefore, various chemotherapy regimens are administered in the treatment of breast cancer. The efficacy of taxane-based adjuvant chemotherapies has been demonstrated in various trials. This trial was designed to retrospectively evaluate the efficacy of taxane-based chemotherapies in lymph node-positive, early-stage Turkish breast cancer patients. 29 patients receiving TAC regimen and 29 patients receiving AC+P regimen were evaluated. 6 courses of TAC regimen were administered every 3 weeks (docetaxel 75 mg/m2, doxorubicine 50 mg/m2, cyclophosphamide 500 mg/m2). The other patient group was administered AC+P regimen (4 courses of doxorubicin 60mg/m2, cyclophosphamide 600 mg/m2 combination every 2 weeks, followed by paclitaxel 175 mg/m2 for 4 courses every 2 weeks). The 1-year, 2-year and 3-year disease-free survival (DFS) rates were 96.3%, 81.1% and 72.8% respectively. No significant difference was detected in DFS between premenopausal and postmenopausal patients on the taxane regimen (p=0.82). There was no significant difference in DFS between estrogen or progesterone receptor positive and negative patients (p=0.46). Disease-free survival of patients receiving TAC and AC+P adjuvant chemotherapy regimen was compared. The follow-up period of patients on AC+P chemotherapy was longer than those receiving TAC (AC+P mean 38.6±12.8 months, TAC mean 17.1±5.4 months). No significant difference was observed upon evaluation of both treatment arms with respect to DFS (p=0.92). In conclusion, this trial once more demonstrated that taxane-based adjuvant chemotherapy was effective and safe in lymph node-positive, early-stage Turkish breast cancer patients." @default.
- W1989093449 created "2016-06-24" @default.
- W1989093449 creator A5043489861 @default.
- W1989093449 creator A5052985063 @default.
- W1989093449 creator A5080257221 @default.
- W1989093449 date "2009-12-01" @default.
- W1989093449 modified "2023-10-18" @default.
- W1989093449 title "Taxane-based adjuvant chemotherapy in node positive, early stage Turkish breast cancer patients" @default.
- W1989093449 cites W1961026612 @default.
- W1989093449 cites W2001133390 @default.
- W1989093449 cites W2043103956 @default.
- W1989093449 cites W2075213874 @default.
- W1989093449 cites W2075557130 @default.
- W1989093449 cites W2098333537 @default.
- W1989093449 cites W2132940815 @default.
- W1989093449 cites W2135800076 @default.
- W1989093449 cites W2160564148 @default.
- W1989093449 cites W2167926320 @default.
- W1989093449 cites W2229395424 @default.
- W1989093449 doi "https://doi.org/10.2478/s11536-009-0075-9" @default.
- W1989093449 hasPublicationYear "2009" @default.
- W1989093449 type Work @default.
- W1989093449 sameAs 1989093449 @default.
- W1989093449 citedByCount "1" @default.
- W1989093449 countsByYear W19890934492016 @default.
- W1989093449 crossrefType "journal-article" @default.
- W1989093449 hasAuthorship W1989093449A5043489861 @default.
- W1989093449 hasAuthorship W1989093449A5052985063 @default.
- W1989093449 hasAuthorship W1989093449A5080257221 @default.
- W1989093449 hasBestOaLocation W19890934491 @default.
- W1989093449 hasConcept C121608353 @default.
- W1989093449 hasConcept C126322002 @default.
- W1989093449 hasConcept C143998085 @default.
- W1989093449 hasConcept C2776694085 @default.
- W1989093449 hasConcept C2776755627 @default.
- W1989093449 hasConcept C2777511904 @default.
- W1989093449 hasConcept C2781190966 @default.
- W1989093449 hasConcept C2781413609 @default.
- W1989093449 hasConcept C530470458 @default.
- W1989093449 hasConcept C71924100 @default.
- W1989093449 hasConcept C90924648 @default.
- W1989093449 hasConceptScore W1989093449C121608353 @default.
- W1989093449 hasConceptScore W1989093449C126322002 @default.
- W1989093449 hasConceptScore W1989093449C143998085 @default.
- W1989093449 hasConceptScore W1989093449C2776694085 @default.
- W1989093449 hasConceptScore W1989093449C2776755627 @default.
- W1989093449 hasConceptScore W1989093449C2777511904 @default.
- W1989093449 hasConceptScore W1989093449C2781190966 @default.
- W1989093449 hasConceptScore W1989093449C2781413609 @default.
- W1989093449 hasConceptScore W1989093449C530470458 @default.
- W1989093449 hasConceptScore W1989093449C71924100 @default.
- W1989093449 hasConceptScore W1989093449C90924648 @default.
- W1989093449 hasIssue "4" @default.
- W1989093449 hasLocation W19890934491 @default.
- W1989093449 hasLocation W19890934492 @default.
- W1989093449 hasOpenAccess W1989093449 @default.
- W1989093449 hasPrimaryLocation W19890934491 @default.
- W1989093449 hasRelatedWork W1966409175 @default.
- W1989093449 hasRelatedWork W2020219107 @default.
- W1989093449 hasRelatedWork W2085844047 @default.
- W1989093449 hasRelatedWork W2155611965 @default.
- W1989093449 hasRelatedWork W2160841316 @default.
- W1989093449 hasRelatedWork W2388730008 @default.
- W1989093449 hasRelatedWork W2631383262 @default.
- W1989093449 hasRelatedWork W2980453143 @default.
- W1989093449 hasRelatedWork W3032029751 @default.
- W1989093449 hasRelatedWork W1503275640 @default.
- W1989093449 hasVolume "4" @default.
- W1989093449 isParatext "false" @default.
- W1989093449 isRetracted "false" @default.
- W1989093449 magId "1989093449" @default.
- W1989093449 workType "article" @default.